BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2821808)

  • 1. Sucralfate versus alginate/antacid in the treatment of peptic esophagitis.
    Evreux M
    Am J Med; 1987 Sep; 83(3B):48-50. PubMed ID: 2821808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sucralfate and alginate/antacid in reflux esophagitis.
    Laitinen S; Ståhlberg M; Kairaluoma MI; Kiviniemi H; Pääkkönen M; Lahtinen J; Poikolainen E; Aukee S
    Scand J Gastroenterol; 1985 Mar; 20(2):229-32. PubMed ID: 2986275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrogastrone for oesophagitis.
    Drug Ther Bull; 1979 Aug; 17(16):63-4. PubMed ID: 228924
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
    Smart HL; Atkinson M
    J R Soc Med; 1990 Sep; 83(9):554-6. PubMed ID: 2213800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children.
    Forbes D; Hodgson M; Hill R
    J Pediatr Gastroenterol Nutr; 1986; 5(4):556-9. PubMed ID: 3016226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oesophagitis and the role of antacid therapy.
    Rhodes J
    Scand J Gastroenterol Suppl; 1982; 75():74-6. PubMed ID: 6959253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of reflux esophagitis with sucralfat].
    Weiss W; Brunner H; Büttner GR; Gabor M; Miederer S; Mittelstaedt A; Olbermann M; Schwamberger K; Witzel L
    Dtsch Med Wochenschr; 1983 Nov; 108(45):1706-11. PubMed ID: 6354663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of four antacids.
    Jacyna MR; Boyd EJ; Wormsley KG
    Postgrad Med J; 1984 Sep; 60(707):592-6. PubMed ID: 6091079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined cimetidine-alginate antacid therapy versus single agent treatment for reflux oesophagitis: results of prospective double-blind randomised clinical trial.
    Eriksen CA; Cheadle WG; Cranford CA; Cuschieri A
    Ann Chir Gynaecol; 1988; 77(4):133-7. PubMed ID: 2855391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of reflux oesophagitis.
    Hamill JJ
    Practitioner; 1983 Apr; 227(1378):637-9. PubMed ID: 6304672
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of gastro-esophageal reflux using a potable gaviscon suspension].
    Guerre J; Neuman M; Bouchet J
    Med Chir Dig; 1982; 11(4):289-95. PubMed ID: 6287126
    [No Abstract]   [Full Text] [Related]  

  • 13. Gaviscon and gastroesophageal reflux in children.
    Buts JP; Leclercq V
    J Pediatr Gastroenterol Nutr; 1987; 6(3):482-3. PubMed ID: 2828595
    [No Abstract]   [Full Text] [Related]  

  • 14. Algicon in the management of gastro-oesophageal reflux.
    Lambert JR; Korman MG; Nicholson L
    Br J Clin Pract Suppl; 1989 Feb; 66():56-8; discussion 61-4. PubMed ID: 2556177
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of Algicon versus Gaviscon in symptomatic gastro-oesophageal reflux.
    Ward AE
    Br J Clin Pract Suppl; 1989 Feb; 66():52-5; discussion 61-4. PubMed ID: 2556176
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
    Chevrel B
    J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of Algicon, an antacid-alginate preparation, in patients with reflux oesophagitis.
    Maxton DG; Miller JP; Whorwell PJ; Butler JK
    Br J Clin Pract; 1988 Sep; 42(9):368-71. PubMed ID: 3075928
    [No Abstract]   [Full Text] [Related]  

  • 18. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
    Buts JP; Barudi C; Otte JB
    Eur J Pediatr; 1987 Mar; 146(2):156-8. PubMed ID: 3032640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1/2-year period.
    Markham C; Reed PI
    Scand J Gastroenterol Suppl; 1980; 65():73-82. PubMed ID: 6259715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gaviscon].
    Ménégol-Couque B; Brard M
    Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.